Publication | Open Access

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial

Pancreatic CancerMedicineImmunologyMetastatic Pancreatic CancerCancer TreatmentImmunotherapyOncologyRadiation Oncology